Healthcare Stakeholders Already Fret Smaller Coverage for LLPs

While the Japanese health ministry unveiled a list of off-patent branded drugs subject to a new coverage rule, some healthcare providers already harbor concerns that insurance benefits might shrink further for such products down the line. Speaking to Jiho on...read more